Skip to main content
Top
Published in: Journal of Ophthalmic Inflammation and Infection 1/2019

Open Access 01-12-2019 | Streptococci | Original research

Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile

Authors: Tarjani Vivek Dave, Vivek Pravin Dave, Savitri Sharma, Roshni Karolia, Joveeta Joseph, Avinash Pathengay, Rajeev R. Pappuru, Taraprasad Das

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 1/2019

Login to get access

Abstract

Purpose

To describe the spectrum of bacterial and fungal pathogens in cases of endophthalmitis requiring evisceration and report their antimicrobial susceptibilities.

Methods

Retrospective, consecutive, and descriptive case series of endophthalmitis that underwent evisceration from January 2004 to December 2017. Vitreous samples from all patients had been investigated for bacteria and fungus using institutional protocol. Bacterial isolates were identified using analytical profile index (API) system until 2010 and Vitek-2 compact system (bioMérieux, France), thereafter. The susceptibility of bacterial isolates to a variety of antibiotics was determined by the Kirby-Bauer disk-diffusion method.

Results

Of 791 cases reviewed, culture positivity was reported in 388 cases (48.92%). Commonest clinical setting of endophthalmitis necessitating evisceration was post-microbial keratitis (58%), followed by post-trauma and post-cataract surgery (14–15%). The commonest isolate was Streptococcus pneumoniae, seen in 68 samples overall (17.52%). One hundred and eighty-three isolates (47.16%) were gram-positive, 86 (22.16%) were gram-negative, and fungi constituted 137 (35.3%) isolates. Streptococcus pneumoniae was the commonest gram-positive bacterial isolate seen in 68/183 samples (37.15%). Among gram-negative organisms, the commonest was Pseudomonas aeruginosa seen in 47/86 (54.65%). Aspergillus spp. formed the commonest fungal isolate, 58/137 (42.33%). The susceptibility of the gram-positive bacteria was highest with vancomycin, 136/147 (92.51%) and for gram-negative bacteria was seen best with imipenem 24/29 (82.75%). Susceptibility to ceftazidime was 31/61 (50.81%) in 31/61.

Conclusion

Endophthalmitis due to Pneumococci, Aspergillus, and Pseudomonas can be very fulminant and progress to require evisceration in spite of prompt and appropriate treatment.
Literature
1.
2.
go back to reference Lu X, Ng DS, Zheng K, Peng K, Jin C, Xia H et al (2016) Risk factors for endophthalmitis requiring evisceration or enucleation. Sci Rep 15:6 Lu X, Ng DS, Zheng K, Peng K, Jin C, Xia H et al (2016) Risk factors for endophthalmitis requiring evisceration or enucleation. Sci Rep 15:6
3.
go back to reference Tsai Y, Tseng S (2001) Risk factors in endophthalmitis leading to evisceration or enucleation. Ophthalmic Surg Lasers 32:208–212PubMed Tsai Y, Tseng S (2001) Risk factors in endophthalmitis leading to evisceration or enucleation. Ophthalmic Surg Lasers 32:208–212PubMed
4.
go back to reference Kunimoto DY, Das TP, Sharma S, Jalali S, Majji AB, Gopinathan U et al (1999) Microbiologic spectrum and susceptibility of isolates: part 1. Postoperative endophthalmitis. Am J Ophthalmol 128:240–242CrossRefPubMed Kunimoto DY, Das TP, Sharma S, Jalali S, Majji AB, Gopinathan U et al (1999) Microbiologic spectrum and susceptibility of isolates: part 1. Postoperative endophthalmitis. Am J Ophthalmol 128:240–242CrossRefPubMed
5.
go back to reference Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Corey RP, Miller D (2004) Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 138:231–236CrossRefPubMed Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Corey RP, Miller D (2004) Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 138:231–236CrossRefPubMed
6.
go back to reference Soriano F, Perez-Trallero E, Pallares R, Meseguer MA, Fleites A, Gene A et al (2006) Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect 12:519–526CrossRefPubMed Soriano F, Perez-Trallero E, Pallares R, Meseguer MA, Fleites A, Gene A et al (2006) Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect 12:519–526CrossRefPubMed
7.
go back to reference Chan SM, Hodge WG, Leonard BC (1998) Postoperative Streptococcus pneumoniae endophthalmitis complicated by meningitis. Arch Ophthalmol 116:951–953PubMed Chan SM, Hodge WG, Leonard BC (1998) Postoperative Streptococcus pneumoniae endophthalmitis complicated by meningitis. Arch Ophthalmol 116:951–953PubMed
8.
go back to reference Shrader SK, Band JD, Lauter CB, Murphy P (1990) The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 162:115–120CrossRefPubMed Shrader SK, Band JD, Lauter CB, Murphy P (1990) The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 162:115–120CrossRefPubMed
9.
go back to reference Rai P, He F, Kwang J, Engelward BP, Chow VTK (2016) Pneumococcalpneumolysin induces DNA damage and cell cycle arrest. Sci Rep 30:22972CrossRef Rai P, He F, Kwang J, Engelward BP, Chow VTK (2016) Pneumococcalpneumolysin induces DNA damage and cell cycle arrest. Sci Rep 30:22972CrossRef
10.
go back to reference Paton JC, Rowan-Kelly B, Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43:1085–1087PubMedPubMedCentral Paton JC, Rowan-Kelly B, Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43:1085–1087PubMedPubMedCentral
11.
go back to reference Han DP, Wisniewski SR, Wilson LA et al (1996) Spectrum and susceptibilities of micorbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 122:1–17CrossRefPubMed Han DP, Wisniewski SR, Wilson LA et al (1996) Spectrum and susceptibilities of micorbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 122:1–17CrossRefPubMed
12.
go back to reference Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC (2008) Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 115:1501–1507CrossRefPubMed Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC (2008) Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 115:1501–1507CrossRefPubMed
14.
go back to reference Rao NA, Hidayat A (2000) Trans Am OphthalmolSoc 98:183–194 Rao NA, Hidayat A (2000) Trans Am OphthalmolSoc 98:183–194
15.
go back to reference Eifrig C, Scott IU, Flynn HW Jr, Miller D (2003) Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology 110:1714–1717CrossRefPubMed Eifrig C, Scott IU, Flynn HW Jr, Miller D (2003) Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology 110:1714–1717CrossRefPubMed
16.
go back to reference Sridhar J, Kuriyan AE, Flynn HW Jr, Miller D (2015) Endophthalmitis caused by Pseudomonas aeruginosa: clinical features, antibiotic susceptibilities and treatment outcomes. Retina 35:1101–1106CrossRefPubMed Sridhar J, Kuriyan AE, Flynn HW Jr, Miller D (2015) Endophthalmitis caused by Pseudomonas aeruginosa: clinical features, antibiotic susceptibilities and treatment outcomes. Retina 35:1101–1106CrossRefPubMed
17.
go back to reference Falavarjani KG, Alemzadeh SA, Habibi A, Hadavandkhani A, Askari S, Pourhabibi A (2017) Pseudomonas aeruginosa endophthalmitis: clinical outcomes and antibiotic susceptibilities. OculImmunolInflamm 25:377–381 Falavarjani KG, Alemzadeh SA, Habibi A, Hadavandkhani A, Askari S, Pourhabibi A (2017) Pseudomonas aeruginosa endophthalmitis: clinical outcomes and antibiotic susceptibilities. OculImmunolInflamm 25:377–381
18.
go back to reference Soong G, Parker D, Magargee M, Prince A (2008) The type II toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol 190:2814–2821CrossRefPubMed Soong G, Parker D, Magargee M, Prince A (2008) The type II toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol 190:2814–2821CrossRefPubMed
19.
go back to reference Barbieri JT (2000) Pseudomonas aeruginosaExoenxyme S, a bifunctional type-III secreted cytotoxin. Int J Med Microbiol 290:381–387CrossRefPubMed Barbieri JT (2000) Pseudomonas aeruginosaExoenxyme S, a bifunctional type-III secreted cytotoxin. Int J Med Microbiol 290:381–387CrossRefPubMed
Metadata
Title
Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile
Authors
Tarjani Vivek Dave
Vivek Pravin Dave
Savitri Sharma
Roshni Karolia
Joveeta Joseph
Avinash Pathengay
Rajeev R. Pappuru
Taraprasad Das
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 1/2019
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-019-0174-y

Other articles of this Issue 1/2019

Journal of Ophthalmic Inflammation and Infection 1/2019 Go to the issue